References
- Aditya, S., and Gupta, S., 2013. Ingenol mebutate: A novel topical drug for actinic keratosis. Indian dermatology online journal, 4 (3), 246.
- Akinwumi, B., Bordun, K.-A., and Anderson, H., 2018. Biological activities of stilbenoids. International journal of molecular sciences, 19 (3), 792.
- Augustin, M.A., Sanguansri, L., and Lockett, T., 2013. Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol. Annals of the New York academy of sciences, 1290 (1), 107–112.
- Davids, L.M., and Kleemann, B., 2010. Combating melanoma: The use of photodynamic therapy as a novel, adjuvant therapeutic tool. Cancer treatment reviews, 37 (6), 465–475.
- Delf Loveymi, B., et al., 2012. Statistical optimization of oral Vancomycin-Eudragit RS nanoparticles using response surface methodology. Iranian journal of pharmaceutical research: IJPR, 11 (4), 1001–1012.
- Fleury, S., and Vianna Lopez, R. F., 2011. Topical administration of anticancer drugs for skin cancer treatment. In: C. La Porta, ed. Skin cancers – risk factors, prevention and therapy. London, UK: InTech.
- Freitas, C., and Müller, R.H., 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions. International journal of pharmaceutics, 168 (2), 221–229.
- Gavini, E., et al., 2005. Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: Preliminary studies. Pharmaceutical development and technology, 10 (4), 479–487.
- Gupta, M., Agrawal, U., and Vyas, S.P., 2012. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert opinion on drug delivery, 9 (7), 783–804.
- Harde, H., et al., 2015. Development of a topical adapalene-solid lipid nanoparticle loaded gel with enhanced efficacy and improved skin tolerability. RSC advances, 5 (55), 43917–43929. https://www.bdbiosciences.com/documents/Cell-Cycle-DNA-DS-Kits-Templates.pdf.
- Jaspart, S., et al., 2005. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert opinion on drug delivery, 2 (1), 75–87.
- Jaspart, S., et al., 2007. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. European journal of pharmaceutics and biopharmaceutics, 65 (1), 47–56.
- Kanavy, H.E., and Gerstenblith, M.R., 2011. Ultraviolet radiation and melanoma. Seminars in cutaneous medicine and surgery, 30 (4), 222–228.
- Küchler, S., et al., 2009. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. International journal of pharmaceutics, 377 (1-2), 169–172.
- Lin, C.-H., et al., 2013. Camptothecin-loaded liposomes with α-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural product. Journal of traditional and complementary medicine, 3 (2), 102–109.
- Luepke, N.P., 1985. Hen’s egg chorioallantoic membrane test for irritation potential. Food and chemical toxicology, 23 (2), 287–291.
- Markus MacGill. 2018. What you should know about melanoma, MedicalNewsToday. Available at: https://www.medicalnewstoday.com/articles/154322.php (Accessed: 20 April 2019).
- Nair, A., et al., 2013. Basic considerations in the dermatokinetics of topical formulations. Brazilian journal of pharmaceutical sciences, 49 (3), 423–434.
- Nidhin, M., et al., 2008. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bulletin of materials science, 31 (1), 93–96.
- Osmond, G.W., et al., 2012. Enhancing melanoma treatment with resveratrol. Journal of surgical research, 172 (1), 109–115.
- Prow, T.W., et al., 2011. Nanoparticles and microparticles for skin drug delivery. Advanced drug delivery reviews, 63 (6), 470–491.
- Rigon, R., et al., 2016. Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies. Molecules, 21 (1), 116.
- Ruela, A.L.M., et al., 2016. Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian journal of pharmaceutical sciences, 52 (3), 527–544.
- Sanna, V., et al., 2004. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS pharmscitech, 5 (2), 17–23.
- Scalia, S., Mezzena, M., and Iannuccelli, V., 2007. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor. Journal of pharmacy and pharmacology, 59 (12), 1621–1627.
- Scalia, S., Young, P.M., and Traini, D., 2015. Solid lipid microparticles as an approach to drug delivery. Expert opinion on drug delivery, 12 (4), 583–599.
- Schmid, M.-H., and Korting, H.C., 1996. Therapeutic progress with topical liposome drugs for skin disease. Advanced drug delivery reviews, 18 (3), 335–342.
- Schwarz, C., et al., 1994. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Journal of controlled release, 30 (1), 83–96. Elsevier,
- Shah, K., et al., 2007. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. International journal of pharmaceutics, 345 (1-2), 163–171.
- Sintov, A.C., and Botner, S., 2006. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. International journal of pharmaceutics, 311 (1-2), 55–62.
- Sonawane, R., et al., 2014. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert opinion on drug delivery, 11 (12), 1833–1847.
- Therdphapiyanak, N., et al., 2013. Development and assessment of tyrosinase inhibitory activity of liposomes of Asparagus racemosus extracts. Asian journal of pharmaceutical sciences, 8 (2), 134–142.
- Tran, M.A., Watts, R.J., and Robertson, G.P., 2009. Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigment cell & melanoma research, 22 (4), 388–399. NIH Public Access,
- Tutrone, W.D., et al., 2003. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod. Cutis, 71 (5), 365–370.
- Uzarska, M., et al., 2013. Chemoprevention of skin melanoma. Melanoma research, 23 (6), 426–433.
- Yuan, J.-J., et al., 2017. Preparation, characterization, and antioxidant activity evaluation of liposomes containing water-soluble hydroxytyrosol from olive. Molecules, 22 (6), 870.
- Yutani, R., et al., 2014. Efficient delivery and distribution in skin of chlorogenic acid and resveratrol induced by microemulsion using sucrose laurate. Chemical and pharmaceutical bulletin, 62 (3), 274–280.